An oligonucleotide blocks interferon-γ signal transduction

Transplantation

Volumn 62, Issue 9, 1996, Pages 1297-1301

  Lee, Peter P ^a   Ramanathan, Murali ^b,c   Hunt, C Anthony ^b   Garovoy, Marvin R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON RECEPTOR; OLIGONUCLEOTIDE;

ANTIGEN EXPRESSION; ARTICLE; ENDOTHELIUM CELL; GRAFT REJECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

CELL LINE; HUMANS; INTERFERON TYPE II; OLIGONUCLEOTIDES; RECEPTORS, INTERFERON; SIGNAL TRANSDUCTION;

EID: 0030447031     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199611150-00021     Document Type: Article

References (24)

1. Niederwieser D, Herold M, Woloszczuk W, et al. Endogenous IFN-gamma during human bone marrow transplantation: analysis of serum levels of interferon and interferon-dependent secondary messages. Transplantation 1990; 50: 620.
2. Nast CC, Zuo XJ, Prehn J, Danovitch GM, Wilkinson A, Jordan SC. Gamma-interferon gene expression in human renal allograft fine-needle aspirates. Transplantation 1994; 57: 498.
3. Slater AD, Klein JB, Czarniecki CW, Sonnenfeld G. The effect of interferon-gamma on rejection and neutrophil function following transplantation. J Interferon Res 1993; 13: 359
4. Rosenberg AS, Finbloom DS, Maniero TG, Van der Meide PH, Singer A. Specific prolongation of MHC class II disparate skin allografts by in vivo administration of anti-IFN-gamma monoclonal antibody. J Immunol 1990; 144: 4648.
5. Stevens HP, van der Kwast TH, van der Meide PH, Vuzevski VD, Buurman WA, Jonker M. Synergistic immunosuppressive effects of monoclonal antibodies specific for interferon-gamma and tumor necrosis factor alpha: a skin transplantation study in the rhesus monkey. Transplantation 1990; 50: 856.
6. Cockfield SM, Urmson J, Pleasants JR, Halloran PF. The regulation of expression of MHC products in mice: factors determining the level of expression in kidneys of normal mice. J Immunol 1990; 144: 2967.
7. Peterlin BM, Andersson G, Lotscher E, Tsang S. Transcriptional regulation of HLA class-II genes. Immunol Res 1990; 9: 164.
8. Glimcher LH, Kara CJ. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 1992; 10: 13.
9. Fellous M, Nir U, Wallach D, et al. Interferon-dependent induction of mRNA for the MHC antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci USA 1982; 79: 3082.
10. Pober JS. Cytokine-mediated activation of vascular endothelium: physiology and pathology. Am J Pathol 1988; 133: 426.
11. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425.
12. Huang EH, Morgan CJ, Sedmak DD, Ferguson RM, Orosz CG. Alloantigenicity of human endothelial cells. IV. Derivation, characterization, and utilization of gonadal vein endothelia to control endothelial alloantigenicity during lymphocyte-endothelial interactions. Transplantation 1994; 57: 703.
13. Szente BE, Soos JM, Johnson HW. The C-terminus of IFN gamma is sufficient for intracellular function. Biochem Biophys Res Commun 1994; 203: 1645.
14. Szente BE, Johnson HM. Binding of IFN gamma and its C-terminal peptide to a cytoplasmic domain of its receptor that is essential for function. Biochem Biophys Res Commun 1994; 201: 215
15. Muller M, Briscoe J, Laxton C, et al. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction [see comments]. Nature 1993; 366: 129.
16. Watling D, Guschin D, Muller M, et al. Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-gamma signal transduction pathway [see comments]. Nature 1993; 366: 166.
17. Ramanathan M, Lantz M, MacGregor RD, et al. Inhibition of interferon-gamma-induced major histocompatibility complex class I expression by certain oligodeoxynucleotides. Transplantation 1994; 57: 612.
18. Fedoseyeva EV, Li Y, Huey B, et al. Inhibition of interferon-gamma-mediated immune functions by oligonucleotides: suppression of human T cell proliferation by downregulation of IFN-gamma-induced ICAM-1 and Fc-receptor on accessory cells. Transplantation 1994; 57: 606.
19. Ramanathan M, Lantz M, MacGregor RD, Garovoy MR, Hunt CA. Characterization of the oligodeoxynucleotide-mediated inhibition of interferon-gamma-induced major histocompatibility complex class I and intercellular adhesion molecule-1. J Biol Chem 1994; 269: 2456.
20. Tam S, Huey B, Li Y, et al. Suppression of interferon-gamma induction of MHC class II and ICAM-1 by a 26-base oligonucleotide composed of deoxyguanosine and deoxythymidine. Transpl Immunol 1994; 2: 285.
21. Larner AC, David M, Feldman GM, et al. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines [see comments]. Science 1993; 261: 1730.
22. Sadowski HB, Shuai K, Darnell J Jr, Gilman MZ. A common nuclear signal transduction pathway activated by growth factor and cytokine receptors [see comments]. Science 1993; 261: 1739
23. Silvennoinen O, Schindler C, Schlessinger J, Levy DE. Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation [see comments]. Science 1993; 261: 1736.
24. Debets R, Savelkoul HF. Cytokine antagonists and their potential therapeutic use. Immunol Today 1994; 15: 455.